CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation

Soomin Ahn, Ji Won Woo, Kyoungyul Lee, So Yeon Park

JPTM. 2020;54(1):34-44. Published online 2019 November 6 DOI: https://doi.org/10.4132/jptm.2019.11.03

HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation

Soomin Ahn, Ji Won Woo, Kyoungyul Lee, So Yeon Park

Journal of Pathology and Translational Medicine. 2020;54(1):34-44

Link1

Link2 Link3

Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status

Tanja Fehm, Sven Becker, Silke Duerr-Stoerzer, Karl Sotlar, Volkmar Mueller, Diethelm Wallwiener, Nancy Lane, Erich Solomayer, Jonathan Uhr

Breast Cancer Research. 2007;9(5):

Link1

Link2 Link3

PO27 HER2 and steroid receptor status in pregnancy-associated breast cancer

M. Litwiniuk, E. Breborowicz

The Breast. 2012;21:S10

Link1 Link2

1–33 Predicting Tissue HER2 Status Using Serum HER2 Levels in Patients with Metastatic Breast Cancer

M.Z. Gilcrease

Breast Diseases: A Year Book Quarterly. 2007;18(1):63-64

Link1 Link2

Assessment of the HER2 status in breast cancer by fluorescence in situ hybridization: a technical review with interpretive guidelines

David G. Hicks, Raymond R. Tubbs

Human Pathology. 2005;36(3):250-261

Link1 Link2

HER2-Positive Breast Cancer

Sarah Sammons, Kimberly Blackwell

Her2-Positive Breast Cancer. 2019;63-74

Link1 Link2

Biosimilars for HER2-Positive Breast Cancer

Hope S. Rugo

Her2-Positive Breast Cancer. 2019;231-237

Link1 Link2

Novel Non–HER2-targeted Therapies in HER2+ Breast Cancer

Marina N. Sharifi, Ruth M. O'Regan

Her2-Positive Breast Cancer. 2019;179-212

Link1 Link2

The prognostic value of HER2 status and efficacy of anti-HER2 therapy in patients with HR-positive mucinous breast cancer: a nationwide study from the Korean Breast Cancer Society

Hyung Suk Kim, Tae Kyung Yoo, Woo Chan Park, Byung Joo Chae

Breast Cancer Research and Treatment. 2020;

Link1

Link2 Link3

Effect of HER2 status on distant recurrence in early stage breast cancer

Kenneth R. Hess, Francisco J. Esteva

Breast Cancer Research and Treatment. 2012;137(2):449-455

Link1

Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. J Pathol Transl Med has participated in CrossRef Text and Data Mining service since January 16, 2015.